VRXA Veraxa Biotech AG
Company Analysis
Latest News
Veraxa's Tumor-Shrinking Data Sends Shares Up 12% — But Can a $1.28 Micro-Cap Turn Mouse Results Into Real Medicine?
Shares of Veraxa Biotech surged 12.3% to $1.28 after the Zurich-based company unveiled its first animal-study results for a novel cancer-drug platform at the...
🟢 Veraxa Biotech is trading 11% up today after first in vivo BiTAC-ADC proof-of-concept data
Veraxa Biotech is trading at $1.28, up 10.53%, after presenting first in vivo proof-of-concept data for its BiTAC-ADC platform on October 13. - In a breast...
🟢 Veraxa Biotech is trading 5% up in pre-market following positive BiTAC-ADC breast cancer model results
Veraxa Biotech is trading at $1.20, up 5.28% in pre-market, reacting to the announcement of its BiTAC-ADC results. - On October 13, 2026, Veraxa Biotech...
🟢 Veraxa Biotech is trading 5% up in after-hours trading
Veraxa Biotech is trading at $1.20, up 5.26% after hours, with no clear company-specific catalyst identified. - The after-hours gain follows a 9.52% decline...
🔴 Veraxa Biotech is trading 10.22% down — decline catalyst remains unclear
Veraxa Biotech is trading 10.22% lower at $1.13; the reason for the decline remains unclear. - Its latest listed release, dated October 7, discussed...
🔴 Veraxa Biotech is trading 5.56% down with no clear catalyst identified
Veraxa Biotech is trading at $1.19, down 5.56%, during October 12, 2026 trading, with no clear catalyst identified. - Its October 7 release discussed...
🟢 Veraxa Biotech is trading 7.94% up in pre-market with no clear catalyst identified
Veraxa Biotech is trading at $1.36, up 7.94%, in pre-market, with no clear company-specific catalyst identified. - The latest company release, dated October...
🔴 Veraxa Biotech is trading 6.2% down in after-hours trading after reversing a 15.60% regular-session gain
Veraxa Biotech is trading 6.21% lower at $1.18 after reversing its 15.60% regular-session gain, with no clear after-hours catalyst identified. - It closed at...
🟢 Veraxa Biotech is trading 11% up today amid renewed biotech IPO appetite
Veraxa Biotech is trading 11.02% up now at $1.21, in line with supportive biotech-sector sentiment. - No company-specific headline was reported for October 9,...
🟢 Veraxa Biotech is trading 6.9% up amid a biotech-sector rally
Veraxa Biotech is trading 6.9% up at $1.17, with a biotech-sector rally potentially supporting shares. - No new company-specific announcement for October 9...
🔴 Veraxa Biotech is trading 5% down; no direct catalyst confirmed
Veraxa Biotech is trading 5% down at $1.14 on October 8, 2026, with biotech-sector weakness the most relevant context; no direct catalyst is confirmed. - The...
🔴 Veraxa Biotech is trading 5.8% down in after-hours trading
Veraxa Biotech is trading 5.8% lower at $1.13 in after-hours trading; no specific catalyst for the decline was reported. - It closed the October 7 regular...
🟢 Veraxa Biotech shares surge 10% after unveiling FDA-aligned preclinical testing strategy
Veraxa Biotech is trading 10.19% up at $1.19 on October 7, 2026, after announcing the implementation of FDA-aligned New Approach Methodologies across its...
Veraxa Rides an FDA Regulatory Wave With a Lab-Methods Announcement — But Can Press Releases Substitute for Revenue?
Shares of Veraxa Biotech shifted sharply higher on October 7, rising 8.3% to $1.17, bucking a weak biotech sector. The catalyst: a press release announcing the...
🟢 Veraxa Biotech is trading 10% up today with FDA-aligned preclinical methods a possible catalyst
Veraxa Biotech is trading at $1.17, up 9.72%; its announcement is a plausible catalyst. - On October 7, 2026, it said it is implementing FDA-aligned New...
🟢 Veraxa Biotech is trading 10% up in pre-market; catalyst remains unclear
Veraxa Biotech is trading 10.19% up in pre-market at $1.19 on October 7, 2026, compared with its October 6 close of $1.08; no confirmed company-specific...
🔴 Veraxa Biotech is trading 5% down today
Veraxa Biotech is trading 5.31% lower at $1.07, with no confirmed company-specific catalyst identified. - The company’s investor-relations page lists its...
🟢 Veraxa Biotech is trading 7.3% up in pre-market
Veraxa Biotech is trading 7.33% up in pre-market at $1.21, compared with its October 5 close of $1.13; no clear overnight catalyst was identified. - The...
🔴 Veraxa Biotech is trading 5.9% down as five-session slide extends
Veraxa Biotech is trading 5.89% down at $1.12 on October 2, 2026, as the immediate catalyst remains unclear. - The decline extends a five-session slide, with...
🟢 Veraxa Biotech is trading 5% up in pre-market
Veraxa Biotech is trading 5.04% higher at $1.25 in pre-market; available evidence does not establish a catalyst. - This compares with the October 1 close of...